ML-7 is a myosin light chain kinase inhibitor that primarily targets the regulation of superoxide anion (O2(-)) release in human neutrophils. This compound effectively inhibits extracellular O2(-) release from stimulated cells while leaving intracellular O2(-) production unaffected. Additionally, ML-7 has been shown to modulate neutrophil activity independently of myosin light chain kinase and offers protective effects on cardiac function during ischemia/reperfusion injury. Its unique properties make it valuable for research in inflammation and cardiac protection mechanisms.
ML-7 is a myosin light chain kinase inhibitor that primarily targets the regulation of superoxide anion (O2(-)) release in human neutrophils. This compound effectively inhibits extracellular O2(-) release from stimulated cells while leaving intracellular O2(-) production unaffected. Additionally, ML-7 has been shown to modulate neutrophil activity independently of myosin light chain kinase and offers protective effects on cardiac function during ischemia/reperfusion injury. Its unique properties make it valuable for research in inflammation and cardiac protection mechanisms.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: